Advanced Activity-Based Protein Profiling Application Strategies for Drug Development

Drug targets and modes of action remain two of the biggest challenges in drug development. To address these problems, chemical proteomic approaches have been introduced to profile targets in complex proteomes. Activity-based protein profiling (ABPP) is one of a growing number chemical proteomic approaches that uses small-molecule chemical probes to understand the interaction mechanisms between compounds and targets. ABPP can be used to identify the protein targets of small molecules and even the active sites of target proteins. This review focuses on the overall workflow of the ABPP technology and on additional advanced strategies for target identification and/or drug discovery. Herein, we mainly describe the design strategies for small-molecule probes and discuss the ways in which these probes can be used to identify targets and even validate the interactions of small molecules with targets. In addition, we discuss some basic strategies that have been developed to date, such as click chemistry-ABPP, competitive strategies and, recently, more advanced strategies, including isoTOP-ABPP, fluoPol-ABPP, and qNIRF-ABPP. The isoTOP-ABPP strategy has been coupled with quantitative proteomics to identify the active sites of proteins and explore whole proteomes with specific amino acid profiling. FluoPol-ABPP combined with HTS can be used to discover new compounds for some substrate-free enzymes. The qNIRF-ABPP strategy has a number of applications for in vivo imaging. In this review, we will further discuss the applications of these advanced strategies.

[1]  Alain Wagner,et al.  Cleavable linkers in chemical biology. , 2012, Bioorganic & medicinal chemistry.

[2]  R. A. Bauer.  Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies. , 2015, Drug discovery today.

[3]  E. Weerapana,et al.  Applications of Copper-Catalyzed Click Chemistry in Activity-Based Protein Profiling , 2014, Molecules.

[4]  Chun Xing Li,et al.  Isotopically-Labeled Iodoacetamide-Alkyne Probes for Quantitative Cysteine-Reactivity Profiling. , 2017, Molecular pharmaceutics.

[5]  H. Overkleeft,et al.  Current developments in activity-based protein profiling. , 2014, Bioconjugate chemistry.

[6]  Dale L Boger,et al.  Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.

[7]  M. Bogyo,et al.  Improved quenched fluorescent probe for imaging of cysteine cathepsin activity. , 2013, Journal of the American Chemical Society.

[8]  H. Overkleeft,et al.  Activity-based protein profiling: an enabling technology in chemical biology research. , 2012, Current opinion in chemical biology.

[9]  Anna E Speers,et al.  Activity‐Based Protein Profiling (ABPP) and Click Chemistry (CC)–ABPP by MudPIT Mass Spectrometry , 2009, Current protocols in chemical biology.

[10]  Steven J Brown,et al.  Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1. , 2011, Journal of medicinal chemistry.

[11]  Edward W. Tate,et al.  Activity-based probes: discovering new biology and new drug targets. , 2011, Chemical Society reviews.

[12]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Steven J Brown,et al.  A fluopol-ABPP HTS assay to identify PAD inhibitors. , 2010, Chemical communications.

[14]  J. Strominger,et al.  Multiple penicillin-binding components in Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, and Escherichia coli. , 1972, The Journal of biological chemistry.

[15]  Steven J Brown,et al.  Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9). , 2010, Bioorganic & medicinal chemistry letters.

[16]  M. McConnell,et al.  Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion , 2016, PloS one.

[17]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[18]  J. Strominger,et al.  Five penicillin-binding components occur in Bacillus subtilis membranes. , 1972, The Journal of biological chemistry.

[19]  B. Cravatt,et al.  The pharmacological landscape and therapeutic potential of serine hydrolases , 2012, Nature Reviews Drug Discovery.

[20]  K. Suk,et al.  A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation. , 2014, Nature chemical biology.

[21]  R. Breinbauer,et al.  Target identification of covalently binding drugs by activity-based protein profiling (ABPP). , 2016, Bioorganic & medicinal chemistry.

[22]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[23]  J. Kozarich.  Activity-based proteomics: enzyme chemistry redux. , 2003, Current opinion in chemical biology.

[24]  Benjamin F. Cravatt,et al.  A roadmap to evaluate the proteome-wide selectivity of covalent kinase inhibitors , 2014, Nature chemical biology.

[25]  Stefano Forli,et al.  Global profiling of lysine reactivity and ligandability in the human proteome. , 2017, Nature chemistry.

[26]  M. Finn,et al.  Copper‐Catalyzed Azide–Alkyne Click Chemistry for Bioconjugation , 2011, Current protocols in chemical biology.

[27]  M. Wright,et al.  Chemical proteomics approaches for identifying the cellular targets of natural products , 2016, Natural product reports.

[28]  Mingzi M. Zhang,et al.  Robust fluorescent detection of protein fatty-acylation with chemical reporters. , 2009, Journal of the American Chemical Society.

[29]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[30]  A. Olson,et al.  Proteome-wide covalent ligand discovery in native biological systems , 2016, Nature.

[31]  J. Olzmann,et al.  Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity. , 2017, ACS chemical biology.

[32]  Steven J Brown,et al.  Substrate-Free High-Throughput Screening Identifies Selective Inhibitors for Uncharacterized Enzymes , 2009, Nature biotechnology.

[33]  Steven R. Tannenbaum,et al.  In situ Proteomic Profiling of Curcumin Targets in HCT116 Colon Cancer Cell Line , 2016, Scientific Reports.

[34]  John Paul Pezacki,et al.  Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. , 2013, Chemistry & biology.

[35]  Bin Liu,et al.  Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum , 2015, Nature Communications.

[36]  C. Skibola,et al.  Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. , 2017, ACS chemical biology.

[37]  T. Spicer,et al.  Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors , 2011, Proceedings of the National Academy of Sciences.

[38]  B. Cravatt,et al.  Enzyme inhibitor discovery by activity-based protein profiling. , 2014, Annual review of biochemistry.

[39]  C. Skibola,et al.  Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity. , 2017, Chemical communications.

[40]  Jennifer A. Prescher,et al.  A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. , 2004, Journal of the American Chemical Society.

[41]  Han-Ming Shen,et al.  Target identification with quantitative activity based protein profiling (ABPP) , 2017, Proteomics.

[42]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[43]  S. Sieber,et al.  Chemical proteomics: ligation and cleavage of protein modifications. , 2013, Current opinion in chemical biology.

[44]  Benjamin F. Cravatt,et al.  A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles , 2013, Nature Methods.

[45]  E. Weerapana,et al.  A Caged Electrophilic Probe for Global Analysis of Cysteine Reactivity in Living Cells. , 2015, Journal of the American Chemical Society.

[46]  David Baker,et al.  Quantitative reactivity profiling predicts functional cysteines in proteomes , 2010, Nature.

[47]  T. Spicer,et al.  Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance. , 2011, Journal of the American Chemical Society.

[48]  L. Shan,et al.  Approaches to target profiling of natural products. , 2012, Current medicinal chemistry.

[49]  Matthew Bogyo,et al.  Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes , 2009, Nature Medicine.

[50]  B. Cravatt,et al.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. , 2008, Annual review of biochemistry.

[51]  Kewu Zeng,et al.  Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy , 2017, Proceedings of the National Academy of Sciences.

[52]  Rozbeh Jafari,et al.  Cellular Thermal Shift Assay Monitoring Drug Target Engagement in Cells and Tissues Using the , 2014 .

[53]  Megan C. Garland,et al.  A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application. , 2016, Cell chemical biology.

[54]  R Riccio,et al.  In cell scalaradial interactome profiling using a bio-orthogonal clickable probe. , 2014, Chemical communications.

[55]  Keith D Paulsen,et al.  Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report , 2016, The Journal of Nuclear Medicine.

[56]  L. Huber.  Is proteomics heading in the wrong direction? , 2003, Nature Reviews Molecular Cell Biology.

[57]  Jongmin Park,et al.  Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. , 2012, Angewandte Chemie.

[58]  D. Hochstrasser,et al.  Current challenges and future applications for protein maps and post‐translational vector maps in proteome projects , 1996, Electrophoresis.

[59]  R. Breinbauer,et al.  Activity-based protein profiling for natural product target discovery. , 2012, Topics in current chemistry.

[60]  Jennifer A. Prescher,et al.  Copper-free click chemistry in living animals , 2010, Proceedings of the National Academy of Sciences.

[61]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[62]  Steven J Brown,et al.  Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes , 2009, Nature Biotechnology.

[63]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[64]  S. Sieber,et al.  Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. , 2008, Angewandte Chemie.

[65]  M. Bogyo,et al.  Activity-Based Protein Profiling , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[66]  A. Saghatelian,et al.  A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors. , 2011, Journal of the American Chemical Society.